As the world continues to move toward globalization, the international travels will keep increasing. This fuels the demand for travel vaccines as the prevalence of infectious diseases are specifically region prone, unlike that of other indications. As vaccines are largely used as a preventive measure against these known infectious diseases, the travelers are advised to follow the region-specific immunization plan.In this report, Technavio covers the present scenario and growth prospects of the global travel vaccines market for 2016-2020 (base year: 2015; forecast end year:2020).

PART 01: Executive summary 6

Highlights 6

PART 02: Scope of the report 7

Market overview 7

Top-vendor offerings 9

PART 03: Market research methodology 11

Research methodology 11

Economic indicators 11

PART 04: Introduction 12

Key market highlights 12

PART 05: Regulatory scenario of vaccines 18

PART 06: Market landscape 22

Market overview 22

Five forces analysis 32

PART 07: Market segmentation by disease type 33

PART 08: Market segmentation by composition 35

Mono vaccines 35

Combination vaccines 38

PART 09: Geographical segmentation 40

Travel vaccines market in Americas 42

Travel vaccines market in EMEA 44

Travel vaccines market in APAC 47

PART 10: Market drivers 50

Growing demand among travelers 50

Additional age group approval 52

Inclusion in NIP 52

PART 11: Impact of drivers 54

PART 12: Market challenges 55

Requires specific storage and distribution system 55

High risk and cost involved in vaccine development 57

Stringent regulatory guidelines 57

PART 13: Impact of drivers and challenges 58

PART 14: Market trends 59

Combination vaccines 59

Increase in R&D activities 60

Public–private initiatives 60

PART 15: Vendor landscape 61

Competitive scenario 61

Other prominent vendors 66

PART 16: Key vendor analysis 71

GlaxoSmithKline 71

Merck 75

Pfizer 77

Sanofi 80

PART 17: Appendix 84

List of abbreviations 84

PART 18: Explore Technavio 86